Second Interim and First Molecular Analysis of the EORTC Randomized Phase III Intergroup CATNON Trial on Concurrent and Adjuvant Temozolomide in Anaplastic Glioma Without 1p/19q Codeletion.
Neuro-Oncology(2019)
Key words
MGMT Promoter Methylation,Tumor Heterogeneity
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined